v3.26.1
Stockholders’ Deficiency
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Stockholders’ Deficiency Stockholders’ Deficiency
Common Stock
The Company has the authority to issue 1,000,000,000 shares of common stock, $0.01 par value per share.
Restricted Stock Units – The Company issued, in connection with the vesting of restricted stock units 7,863 and 4,999 shares of the Company’s common stock during the three months ended June 30, 2026 and 2025, respectively, as reflected on the condensed consolidated statements of stockholders’ deficiency. The Company issued, in connection with the vesting of restricted stock units, 15,723 and 12,498 shares of the Company’s common stock during the six months ended June 30, 2026 and 2025, respectively, as reflected on the condensed consolidated statements of stockholders’ deficiency.
Common Stock Withheld – The Company recorded the repurchase of 0 shares related to vested restricted common stock for the payment for taxes of $0 during the three months ended June 30, 2026, and the repurchase of 2,061 shares related to vested restricted common stock for the payment for taxes of $12 during the three months ended June 30, 2025, as reflected on the condensed consolidated statements of stockholders’ deficiency.